Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss

OBJECTIVE: To explore the effects of anti-tumour necrosis factor (TNF)α antibody therapy on bone mineral density (BMD) of the lumbar spine and femur neck in patients with rheumatoid arthritis (RA). METHODS: A total of 50 patients with active RA (DAS28⩾3.2) who started adalimumab (40 mg subcutaneousl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijbrandts, C A, Klaasen, R, Dijkgraaf, M G W, Gerlag, D M, van Eck-Smit, B L F, Tak, P P
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2008
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945478/
https://www.ncbi.nlm.nih.gov/pubmed/18408246
http://dx.doi.org/10.1136/ard.2008.091611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945478/
https://www.ncbi.nlm.nih.gov/pubmed/18408246
http://dx.doi.org/10.1136/ard.2008.091611

Ejemplares similares